| Madeline Patricia Cervini, PT | |
|
133 Fairfield St, Saint Albans, VT 05478-1726 | |
| (802) 524-1064 | |
| (802) 524-1025 |
| Full Name | Madeline Patricia Cervini |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 28 Years |
| Location | 133 Fairfield St, Saint Albans, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124283833 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 0400003166 (Vermont) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Momentum Physical Therapy Plc | 5890795348 | 9 |
News Archive
Scientists today reported identification of the first substance in smokeless tobacco that is a strong oral carcinogen ― a health risk for the 9 million users of chewing tobacco, snuff and related products in the U.S. ― and called upon the federal government to regulate or ban the substance.
Cristina Martinez's spinal operation in Houston was expected to be routine. But after destabilizing her spine, the surgeon discovered the implant he was ready to put in her back was larger than he wanted to use — and the device company's sales rep didn't have a smaller size on hand, according to a report he filed about the operation.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva® (erlotinib) in patients with non-small cell lung cancer (NSCLC). This is the first of multiple trials that Merrimack and sanofi-aventis expect to initiate in 2010 as part of a broad Phase 2 clinical development program for MM-121.
The long and challenging effort to find blood-borne markers for cancer and other diseases may soon enter a new realm of success using a new nanoparticle that preferentially and rapidly removes small proteins and other molecules from blood while simultaneously protecting them from degradation.
› Verified 6 days ago
| Provider Name | Momentum Physical Therapy Plc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1346318565 PECOS PAC ID: 5890795348 Enrollment ID: O20070105000349 |
News Archive
Scientists today reported identification of the first substance in smokeless tobacco that is a strong oral carcinogen ― a health risk for the 9 million users of chewing tobacco, snuff and related products in the U.S. ― and called upon the federal government to regulate or ban the substance.
Cristina Martinez's spinal operation in Houston was expected to be routine. But after destabilizing her spine, the surgeon discovered the implant he was ready to put in her back was larger than he wanted to use — and the device company's sales rep didn't have a smaller size on hand, according to a report he filed about the operation.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva® (erlotinib) in patients with non-small cell lung cancer (NSCLC). This is the first of multiple trials that Merrimack and sanofi-aventis expect to initiate in 2010 as part of a broad Phase 2 clinical development program for MM-121.
The long and challenging effort to find blood-borne markers for cancer and other diseases may soon enter a new realm of success using a new nanoparticle that preferentially and rapidly removes small proteins and other molecules from blood while simultaneously protecting them from degradation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Madeline Patricia Cervini, PT 133 Fairfield St, Saint Albans, VT 05478-1726 Ph: (802) 524-1064 | Madeline Patricia Cervini, PT 133 Fairfield St, Saint Albans, VT 05478-1726 Ph: (802) 524-1064 |
News Archive
Scientists today reported identification of the first substance in smokeless tobacco that is a strong oral carcinogen ― a health risk for the 9 million users of chewing tobacco, snuff and related products in the U.S. ― and called upon the federal government to regulate or ban the substance.
Cristina Martinez's spinal operation in Houston was expected to be routine. But after destabilizing her spine, the surgeon discovered the implant he was ready to put in her back was larger than he wanted to use — and the device company's sales rep didn't have a smaller size on hand, according to a report he filed about the operation.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva® (erlotinib) in patients with non-small cell lung cancer (NSCLC). This is the first of multiple trials that Merrimack and sanofi-aventis expect to initiate in 2010 as part of a broad Phase 2 clinical development program for MM-121.
The long and challenging effort to find blood-borne markers for cancer and other diseases may soon enter a new realm of success using a new nanoparticle that preferentially and rapidly removes small proteins and other molecules from blood while simultaneously protecting them from degradation.
› Verified 6 days ago
Dr. Kaylee Allison Wolitzer, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Home Health Cir # 1, Saint Albans, VT 05478 Phone: 802-527-7531 | |
Heidi Magill, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 Fairfax Rd, Saint Albans, VT 05478 Phone: 802-752-1666 | |
Mrs. Sarah W Nielsen, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 133 Fairfield St, Saint Albans, VT 05478 Phone: 802-524-1064 Fax: 802-524-1025 | |
Sophie Zimmerman, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 596 Sheldon Rd, Saint Albans, VT 05478 Phone: 802-524-6534 | |
Lori Deering, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 260 Crest Rd Ste 101, Saint Albans, VT 05478 Phone: 802-524-1223 Fax: 802-524-1095 | |
Rehab Zone Physical Therapist Medicare: Medicare Enrolled Practice Location: 248 N Main St, Saint Albans, VT 05478 Phone: 802-309-0430 |